MedPath

sefulness of postoperative probiotics in patients who underwent right hemicolectomy for colon cancer

Not Applicable
Recruiting
Conditions
Neoplasms
Registration Number
KCT0005392
Lead Sponsor
The Catholic University of Korea, Uijeongbu St. Mary’s Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

? Adult men and women aged 20 to 80 years old
? Patients with colorectal cancer diagnosed histologically and imagingly, and who are scheduled for right colon resection
? Before the clinical trial begins, consent to participation in this clinical trial and sign a written consent.

Exclusion Criteria

? Those suffering from metastatic colon cancer
? Those who received chemotherapy or radiation therapy before surgery
? Patients with a history of severe cerebrovascular disease (cerebral infarction, cerebral hemorrhage, etc.), severe heart disease (unsafe angina, myocardial infarction, arrhythmia requiring heart failure treatment)
? Those with neurological or psychologically important medical history or currently suffering from a disease
? Those with a history of alcoholism or substance abuse
? People with immune system, infectious, gastrointestinal diseases (inflammatory bowel disease)
? Uncontrolled thyroid disease
? Creatinine is more than twice the normal upper limit of the test
? Those whose AST(GOT) and ALT(GPT) are more than 3 times the normal range
? Patients with uncontrolled hypertension (160/100mmHg or more, measured after 10 minutes of rest for the subject)
? Patients with uncontrolled diabetes (fasting blood sugar greater than 180mg/dl)
? Those who have taken or used probiotics or antibiotics within the last 1 week
? Pregnant women, lactating women, women of childbearing age who have a pregnancy plan or who do not agree with the selection of appropriate contraceptive methods
? Patients who have not performed the planned operation (right colon resection)
? Those who are judged to be inappropriate for this clinical trial

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluation of bowel movements using the number of bowel movements per day and Bristol stool chart
Secondary Outcome Measures
NameTimeMethod
Cancer patient quality of life questionnaire (EORTC QLQ-C30)
© Copyright 2025. All Rights Reserved by MedPath